Should I buy Philip Morris stock in 2025?
Is it the right time to buy Philip Morris?
ScorePhilip Morris International (PM), trading on the NYSE, currently hovers around $177.87 per share with a three-month average daily volume of approximately 6.07 million shares. The stock has enjoyed a strong year-to-date climb of 47.79%, supported by robust Q1 2025 results where revenue and net income surpassed forecasts. A historic regulatory event in January—the FDA's approval of 20 ZYN nicotine pouch products—has unlocked significant growth potential in the U.S. market. In Q1, ZYN shipments soared 53% year-on-year, solidifying PM's innovative edge in smoke-free products. This transformation has underpinned a constructive market sentiment, as more investors recognize PM's resilience amid evolving tobacco regulations and shifting consumer preferences in the consumer defensive sector. The company’s strategic focus on reduced-risk products, strong free cash flow, and global reach further enhance its appeal. According to the consensus from 12 leading national and international banks, the target price for PM is established at $231.23, which many view as a credible medium-term benchmark. These factors collectively position Philip Morris as a compelling option for investors seeking both growth and steady income in today’s market.
- ✅Strong revenue growth driven by ZYN and IQOS smoke-free products.
- ✅Leading global market position with expansion in over 180 countries.
- ✅Robust free cash flow generation supporting attractive 2.96% dividend yield.
- ✅Recent FDA approval for ZYN boosts future U.S. market growth prospects.
- ✅Consistent performance above analyst expectations with raised guidance.
- ❌Significant exposure to foreign exchange rates may impact earnings.
- ❌Ongoing regulatory scrutiny could affect growth in certain markets.
Score- ✅Strong revenue growth driven by ZYN and IQOS smoke-free products.
- ✅Leading global market position with expansion in over 180 countries.
- ✅Robust free cash flow generation supporting attractive 2.96% dividend yield.
- ✅Recent FDA approval for ZYN boosts future U.S. market growth prospects.
- ✅Consistent performance above analyst expectations with raised guidance.
Is it the right time to buy Philip Morris?
- ✅Strong revenue growth driven by ZYN and IQOS smoke-free products.
- ✅Leading global market position with expansion in over 180 countries.
- ✅Robust free cash flow generation supporting attractive 2.96% dividend yield.
- ✅Recent FDA approval for ZYN boosts future U.S. market growth prospects.
- ✅Consistent performance above analyst expectations with raised guidance.
- ❌Significant exposure to foreign exchange rates may impact earnings.
- ❌Ongoing regulatory scrutiny could affect growth in certain markets.
Score- ✅Strong revenue growth driven by ZYN and IQOS smoke-free products.
- ✅Leading global market position with expansion in over 180 countries.
- ✅Robust free cash flow generation supporting attractive 2.96% dividend yield.
- ✅Recent FDA approval for ZYN boosts future U.S. market growth prospects.
- ✅Consistent performance above analyst expectations with raised guidance.
- What is Philip Morris?
- What is the price of Philip Morris stock?
- Our Full Analysis of the Philip Morris Stock
- How to buy Philip Morris stock in the US?
- Our 7 tips for buying Philip Morris stock
- The latest news about Philip Morris
- FAQ
Why trust HelloSafe ?
At HelloSafe, our expert has been tracking the performance of Philip Morris for over three years. Every month, hundreds of thousands of users in the US trust us to analyze market trends and identify the best investment opportunities. Our analyses are for informational purposes only and do not constitute investment advice. In accordance with our ethical charter, we have never been, and will never be, compensated by Philip Morris.
What is Philip Morris?
| Indicator | Value | Analysis |
|---|---|---|
| 🏳️ Nationality | United States | Headquartered in Connecticut, Philip Morris operates globally from the US base. |
| 💼 Market | NYSE | Listed on the New York Stock Exchange, ensuring liquidity for US investors. |
| 🏛️ ISIN code | US7181721090 | This ISIN identifies Philip Morris for secure US and international trading. |
| 👤 CEO | Jacek Olczak | Jacek Olczak leads ongoing innovation and the smoke-free product transformation. |
| 🏢 Market cap | $273.81 billion | A large market cap shows strong investor confidence and resilient business size. |
| 📈 Revenue | $9.3 billion (Q1 2025) | Revenue growth accelerates from strong ZYN and IQOS performance in key markets. |
| 💹 EBITDA | $3.5 billion (Q1 2025, est.) | High EBITDA signals solid profitability and efficient operations this quarter. |
| 📊 P/E Ratio (Price/Earnings) | 28.01 | The elevated P/E reflects investor optimism but suggests high growth is expected. |
What is the price of Philip Morris stock?
The price of Philip Morris stock is rising this week. Currently trading at $177.87, the stock has gained $1.96 (+1.11%) in the last 24 hours, while for the week it is down 1.95%. Philip Morris holds a market capitalization of $273.81 billion, with an average three-month volume of 6.07 million shares. The company posts a P/E ratio of 28.01, a dividend yield of 2.96%, and a stock beta of 0.54. These figures suggest relative stability alongside attractive income potential for long-term investors.
Our Full Analysis of the Philip Morris Stock
After a detailed review of Philip Morris’s latest financial results and its outstanding share performance over the past three years, our proprietary algorithm leverages multi-source analysis—combining fundamentals, technical signals, market sentiment, and sector benchmarks. The recent earnings and peer comparison create a compelling narrative. So, why might Philip Morris stock once again become a strategic entry point into the consumer staples sector in 2025?
Recent performance and market context
The price of Philip Morris stock has demonstrated notable strength, currently trading at $177.87 and gaining over 45% in just six months and more than 75% year-on-year. Its year-to-date gain (+47.79%) far outpaces major defensive sector and S&P 500 benchmarks, a testament to the group’s operational excellence and successful transformation strategy. Key positive drivers include the historical FDA authorization for 20 ZYN products in the US in January 2025 and robust demand propelling ZYN shipments to 202 million cans in the first quarter, up 53% year-on-year. Management’s acceleration of ZYN sales targets to 800–840 million cans for 2025 highlights continued momentum. Philip Morris benefits from a supportive macroeconomic environment and sector backdrop: consumer staple stocks are well positioned as investors seek stable, dividend-paying companies with strong global brands in a context of persistent volatility and sector rotation.
Technical analysis
A detailed technical breakdown reveals a stock consolidating at the higher end of its annual range, in a favorable pause following a prolonged rally. Despite a short-term dip of 1.95% this week, the underlying structure remains robust: the RSI (47.22) is neutral, indicating room for upside moves. The stochastic oscillator (58.98) and Williams %R (-20.73) both signal renewed buying interest, and while the MACD shows a brief sell phase, all major moving averages from 20 to 200 days are clustered just below the price, supporting a bullish interpretation if momentum resumes. The key technical support is now well established at $175.30, with a major resistance at the $186.69 yearly high. The recent “consolidation after a strong rally” scenario, combined with short-term oscillators turning up, suggests that the stock may be gearing up for a new bullish phase, providing a constructive entry setup for technically minded investors.
Fundamental analysis
From a fundamental standpoint, Philip Morris offers a rare combination of accelerating revenue, expanding margins, and strategic clarity. First quarter 2025 revenues rose 5.8% (to $9.3 billion) with organic sales up 10.2%, outpacing analyst forecasts. Net income jumped 25% to $2.68 billion, while adjusted EPS exceeded consensus, confirming operational leverage and prudent cost management. The stock’s 28.01x P/E, in line with premium consumer staples, reflects justified confidence given projected earnings accretion from new product launches and ongoing portfolio transformation. Investors benefit from a solid 2.96% dividend yield ($5.40 per year), underpinned by robust free cash flow generation—$8.56 billion in the last year. Philip Morris’s innovation engine (notably IQOS and ZYN) has driven market share gains globally, consolidating its leadership in the smoke-free transformation and positioning it as a sector frontrunner. Its premium brand portfolio, geographic reach in over 180 countries, and consistent investment in reduced-risk products further bolster structural strengths and support an attractive valuation even at these levels.
Volume and liquidity
Sustained high trading volume, averaging 6.07 million shares per day, demonstrates strong interest from both institutional and retail investors. The company’s large free float of 1.55 billion shares enables smooth price discovery and supports dynamic, efficient valuation—minimizing liquidity risk for active traders and investors. Such volume patterns reinforce market confidence, affirming that Philip Morris is not only well owned but also broadly followed by the investment community, which contributes to price stability and responsiveness to news or earnings surprises.
Catalysts and positive outlook
Several powerful catalysts argue for sustained upside potential in Philip Morris stock. The FDA’s unprecedented approval of ZYN in the US unlocks a new phase of growth in a rapidly expanding nicotine pouch segment, as evidenced by the company’s sharp upward revision to annual ZYN shipment targets. Further innovation in reduced-risk products such as IQOS, and the potential for additional “Modified Risk Tobacco Product” (MRTP) regulatory wins, reinforce the upward trend. The company’s ESG efforts—embedding sustainability across its supply chain and establishing a pathway for tobacco harm reduction—further underpin growth, meet evolving consumer standards, and continue to attract long-term-focused capital. Globally, sector fundamentals are highly favorable: consumers increasingly prefer reduced-risk alternatives, major institutional investors seek exposure to stable cash generation and dividend growth, and potential US regulatory clarity offers room for future re-rating.
Investment strategies
Philip Morris appears well positioned for both tactical and strategic entry. From a short-term perspective, recent consolidation near the $175–$180 zone, coupled with the technical pattern and oscillators, makes a compelling case for accumulation ahead of the next bullish impulse. For medium-term investors, the confirmed uptrend supported by positive earnings momentum, strong dividend policy, and market-moving catalysts like new product launches suggest accumulated positions could deliver attractive returns into 2025 and beyond. Over the long term, Philip Morris’s commitment to innovation, market share expansion in reduced-risk products, and proven ability to adapt to regulatory shifts make this a standout compounder in a sector prized for stability and yield. Current entry levels may represent an ideal positioning, especially as the company has weathered industry headwinds and now leads sector transformation.
Is it the right time to buy Philip Morris?
Considering consistent earnings beats, robust cash flows, and the growing success of ZYN and IQOS, the fundamentals justify renewed investor interest. The stock’s rally over the past year has been underpinned by tangible progress in portfolio transformation, regulatory breakthroughs, and rising analyst estimates. Technical consolidation at the high of the range may offer an exceptional entry point for both new and existing investors. Momentum remains strong as market sentiment tilts positive, underpinned by sector resilience, defensive attributes, and unique growth levers. In summary, Philip Morris stock stands on the threshold of multiple bullish catalysts and seems to represent an excellent opportunity in the consumer defensive space for 2025.
Philip Morris continues to offer investors a blend of defensive strength and dynamic growth, positioning it as a compelling candidate for portfolio consideration as the next major phase of sector transformation unfolds.
How to buy Philip Morris stock in the US?
Buying Philip Morris stock online is straightforward and secure when you use a regulated broker in the US. You can invest in Philip Morris either by purchasing shares outright (spot buying) or by trading Contracts for Difference (CFDs), each with its own advantages. Understanding these methods helps you choose the right strategy for your investment goals—compare brokers further down the page to find the best fit for your needs.
Spot buying
Buying Philip Morris stock “for cash” means directly acquiring shares through your broker, making you an actual shareholder. Fees are typically a fixed commission per order and may range from $0 to $10 per trade, depending on the broker.
Example of a gain scenario on Philip Morris shares
If the Philip Morris share price is $177.87, you can buy around 5 shares with a $1,000 stake, including a brokerage fee of around $5.
✔️ Gain scenario: If the share price rises by 10%, your shares are now worth $1,100. Result: +$100 gross gain, i.e. +10% on your investment.
Trading via CFD
CFDs (Contracts for Difference) allow you to trade on the price movements of Philip Morris without owning the underlying shares. CFDs let you use leverage to amplify your exposure, but you’ll pay the spread (the difference between buy and sell price) and possible overnight financing charges if you hold your position for several days.
Gain scenario
You open a CFD position on Philip Morris shares with 5x leverage and a $1,000 stake. This gives you a market exposure of $5,000.
If the stock rises by 8%, your position gains 8% × 5 = 40%.
Result: +$400 gain, on a bet of $1,000 (excluding fees).
Final advice
Before investing in Philip Morris, take time to compare brokers’ fees, available platforms, and trading conditions—this ensures the method you choose matches your objectives and risk tolerance. Ultimately, the right choice depends on whether you prefer direct share ownership for long-term growth or the flexibility of leveraged CFD trading for short-term opportunities. Check our broker comparison below to make an informed decision.
Check out the USA's best brokers!Compare brokersOur 7 tips for buying Philip Morris stock
| 📊 Step | 📝 Specific tip for Philip Morris |
|---|---|
| Analyze the market | Review recent financials and growth in reduced-risk products for Philip Morris to spot favorable buying trends and sector momentum. |
| Choose the right trading platform | Select a US-regulated broker with low commissions that offers easy access to NYSE and tools to track Philip Morris’s performance. |
| Define your investment budget | Decide how much to invest in Philip Morris based on your risk tolerance and ensure you diversify with other defensive or growth stocks. |
| Choose a strategy (short or long term) | For Philip Morris, consider a medium- to long-term approach to capture both dividend income and innovation-driven appreciation. |
| Monitor news and financial results | Follow quarterly reports and regulatory approvals, especially for the ZYN line, as these often influence Philip Morris’s share price. |
| Use risk management tools | Set stop-loss and limit orders to protect gains and manage volatility, especially as Philip Morris can react quickly to market or legal news. |
| Sell at the right time | Look to realize gains during technical highs or when new product catalysts are priced in, aiming for a disciplined and strategic exit. |
The latest news about Philip Morris
Philip Morris reports strong year-to-date growth and maintains high stock price momentum. With a YTD performance of +47.79% and a one-year gain exceeding 75%, Philip Morris’s share price continues to demonstrate exceptional resilience and growth potential. The current price, at $177.87, remains near the upper end of its 52-week range, illustrating ongoing investor interest and positive sentiment in the US market.
Record Q2 sales growth driven by nicotine pouch product ZYN in the US. Recent quarterly results highlight Philip Morris’s remarkable performance in the US, where shipments of ZYN nicotine pouches jumped by 53% year-over-year, reaching 202 million cans. Following a landmark FDA approval in January, ZYN’s US revenue acceleration cements Philip Morris’s leading role in the American market for reduced-risk, smoke-free products.
US regulatory approval further strengthens the company's growth prospects. The FDA’s recent authorization of 20 ZYN products marks a milestone, establishing a robust legal footing for the brand in the United States. This regulatory win is expected to drive further market share gains and open additional distribution channels, reinforcing growth forecasts and investor confidence.
Consensus outlook for Philip Morris in the United States remains optimistic. Leading analysts have maintained or raised their targets for Philip Morris based on the sustained growth of reduced-risk product sales and the company’s strategic focus on the US market. The stock’s consensus price target ($178.78) aligns closely with current trading levels, reflecting both stability and conviction in the brand’s US growth strategy.
Continued robust cash flow generation and sustained US dividend yield attract investors. Philip Morris continues to post strong cash flow figures, supporting its commitment to a stable and attractive dividend yield of nearly 3%. This combination of reliable income and growth potential positions the stock as an appealing choice for US investors seeking both stability and upside in the evolving tobacco and nicotine alternatives sector.
FAQ
What is the latest dividend for Philip Morris stock?
Philip Morris currently pays a quarterly dividend of $1.35 per share, with the most recent payment in June 2025. This translates to an annualized $5.40 per share, offering a historically stable and consistent dividend. The dividend yield stands at around 2.96%, and the company maintains a strong commitment to regular distributions.
What is the forecast for Philip Morris stock in 2025, 2026, and 2027?
Based on the current price, end of 2025 is forecast at $231, end of 2026 at $267, and end of 2027 at $356. These projections reflect the company’s strong performance in the reduced-risk products market and growing demand for nicotine alternatives worldwide.
Should I sell my Philip Morris shares?
For most investors, holding onto Philip Morris shares may be a prudent choice. The company boasts an established dividend, strong geographic diversification, and solid prospects from its transformation toward smoke-free products. Given its historical resilience and sector momentum, maintaining exposure often aligns with mid- to long-term investment strategies.
Are Philip Morris dividends eligible for US retirement accounts like 401(k) or IRA?
Yes, Philip Morris stock is eligible for inclusion in US retirement plans such as 401(k) and IRA accounts. Dividends received within these accounts are typically tax-deferred, and there is no US withholding tax for domestic investors. However, ordinary taxation applies upon withdrawal of funds in retirement.
What is the latest dividend for Philip Morris stock?
Philip Morris currently pays a quarterly dividend of $1.35 per share, with the most recent payment in June 2025. This translates to an annualized $5.40 per share, offering a historically stable and consistent dividend. The dividend yield stands at around 2.96%, and the company maintains a strong commitment to regular distributions.
What is the forecast for Philip Morris stock in 2025, 2026, and 2027?
Based on the current price, end of 2025 is forecast at $231, end of 2026 at $267, and end of 2027 at $356. These projections reflect the company’s strong performance in the reduced-risk products market and growing demand for nicotine alternatives worldwide.
Should I sell my Philip Morris shares?
For most investors, holding onto Philip Morris shares may be a prudent choice. The company boasts an established dividend, strong geographic diversification, and solid prospects from its transformation toward smoke-free products. Given its historical resilience and sector momentum, maintaining exposure often aligns with mid- to long-term investment strategies.
Are Philip Morris dividends eligible for US retirement accounts like 401(k) or IRA?
Yes, Philip Morris stock is eligible for inclusion in US retirement plans such as 401(k) and IRA accounts. Dividends received within these accounts are typically tax-deferred, and there is no US withholding tax for domestic investors. However, ordinary taxation applies upon withdrawal of funds in retirement.
